Close Menu

Plasticell

Plasticell has received a £750,000 ($1.2 million) grant from the UK's Technology Strategy Board (TSB), a business-led and government-supported research funder, to support a high-throughput screening project aimed at developing stem cell manufacturing protocols.

Proteomics firm Cellzome said this week it has won more than €2.3 million ($3.1 million) in grants funding its participation in three separate research projects.

Plasticell has developed "serum-free protocols that direct the differentiation of Stemnion's stem cells into hard-to-obtain lineages."

Plasticell has formed a spinout called Progenitor Labs, which will focus on regenerative drug discovery.

The British stem cell research tools firm plans to use the funds to expand its business development and marketing activities.

The collaboration involves using Sigma-Aldrich's CompoZr zinc finger nuclease technology and Plasticell's CombiCult high-throughput screening system.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.